PAINWeekEnd Conference New Orleans 2022

Course Agenda

(Faculty and courses subject to change)

8:00a-9:00a — Registration, Breakfast, Coffee, and Exhibits

9:00a-10:00a — Everybody's Greasing Up, But Should You Rub it In? A Review of Topical Analgesics

Faculty: Timothy J. Atkinson, PharmD, BCPS, CPE

Topical analgesics are often recommended in clinical practice, but differences between formulations and routes of administration lead to confusion. In addition to commercially prepared topical analgesics, compounded topical analgesics are highly promoted and widely utilized from compounding pharmacies with individualized recipes of multiple combined medications, at substantial cost. To assist providers with tough decisions in this area, the available clinical trials supporting use will be reviewed along with formulations, locations, and doses where their use have been shown to the be most effective. This session will review the role of various topical analgesics as well as explore the rationale for “topical polypharmacy” with compounded drugs

UAN: 0530-0000-22-031-L08-P
Rx hours: 0.10

10:00a-10:15a — Break/Exhibits

10:15a-11:15a — Clinical Update: Utilizing Topical Analgesics for Diabetic Peripheral Neuropathy

Faculty: Charles E. Argoff, MD

Painful diabetic neuropathy is a challenging condition to treat. This course will review the prevalence and impact of painful diabetic neuropathy as well as explore how available topical therapies for this condition can be incorporated into one’s practice. Systemic therapies will also be discussed to provide context for the discussion of topical therapies and because topical therapies are often used in conjunction with systemic treatments.

UAN: 0530-0000-22-008-L01-P
Rx hours: 0.50

Supported by an educational grant from Averitas Pharma, Inc.

11:15a-12:15p — Who's Looking at You, Doc? A Rational Response to 2021 Perspectives on Opioid Prescribing

Faculty: Jennifer Bolen, JD

Recent litigation against opioid manufacturers and prescribers—and the uptick in drug overdose cases, behavioral health needs, and access to pain management solutions during the COVID-19 pandemic—continues to present frontline practitioners with daily practice challenges. Who’s looking at us now? What are they looking for now? What can be done to minimize the potential of becoming embroiled in a legal battle over your controlled substance prescribing decisions? How does the frontline healthcare practitioner achieve a rational response to various stakeholder mandates involving controlled substances? Of course, frontline practitioners cannot control healthcare access barriers resulting from the controlled substance prescribing and utilization choices of others, but they can control their response to them. Using clinical vignettes and interactive group discussion, this course will examine specific practice challenges involving controlled substance prescribing and evaluate viable solutions for improving medical record documentation of decision-making and individualized patient care.

UAN: 0530-0000-22-024-L08-P
Rx hours: 0.00

12:15p-12:30p — Break/Exhibits

12:30p-1:30p — Building Confidence and Establishing Best Practices for Administering QUTENZA^® (capsaicin) 8% topical system*

Faculty: Stephanie Simon, APRN

This hands-on workshop will allow you to practice the application steps and technique surrounding a QUTENZA treatment. Demonstration topical systems and patient actors will be available for you to gain hands-on experience and develop best practices.

Sponsored by Averitas Pharma, Inc.

Lunch will be served.

*Not certified for credit

1:30p-2:30p — Chronic Pain in the Year of a Pandemic: Advanced Practice Provider Edition

Faculty: Brett B. Snodgrass, FNP-C, CPE, FACPP, FAANP

What happened in the world of chronic pain during the pandemic? What has changed and what has stayed the same? This session is for the advanced practice provider, and we will talk about what we’ve learned and how our practice of chronic pain has changed. We’ll discuss how to take better care of ourselves and our patients moving forward.

UAN: 0530-0000-22-030-L08-P
Rx hours: 0.30

2:30p-2:40p — Break/Exhibits

2:40p-3:40p — Through the Lens of Experts: Meaningful Risk Mitigation and Patient Education

Faculty: Jennifer Bolen, JD

Those who have been on either side of a courtroom battle on chronic opioid therapy have seen experts and lawyers spend a great deal of time arguing about the extent and nature of risk mitigation and patient education necessary to demonstrate that the prescriber issued a valid controlled substance prescription. The focus of expert testimony is on whether the prescriber engaged in meaningful risk evaluation and monitoring practices, and whether the prescriber individualized medical care for the patient, based on specific history and behaviors as treatment went on. This course will use published medical expert testimony and common expert reports of illegal and insufficient risk mitigation and patient education. The main goal is to facilitate a prescriber's self-audit of risk mitigation practices and to help attendees improve documentation of risk mitigation protocols and patient education efforts. A proactive approach to meaningful risk mitigation is necessary for protecting patient access to quality pain care and creating a framework within which other practitioners may confidently assume care for patients when necessary, and demonstrating appropriate prescribing of chronic opioid therapy.

UAN: 0530-0000-22-022-L03-P
Rx hours: 0.40

3:40p-4:40p — From the Ivory Tower: The Data-Driven Strategy CMS, Health Plans, and State Governments Use to Review
a Provider’s Clinical Practice

Faculty: Timothy J. Atkinson, PharmD, BCPS, CPE

Payers are becoming more sophisticated and less risk-tolerant in their approach to performing opioid prescribing surveillance and often reach out to prescriber practices when they perceive excessive risk. Providers are encouraged to make changes to increase safety or face costly remediation or network termination, and they often express confusion regarding data or metrics used to make these decisions. We will give providers perspective on the methodology that many prominent payers use to evaluate a provider's practice. It is a complex process employed by payers to leverage available medical and pharmacy claims data and turn raw data into measurable metrics to document clinical outcomes. By itself, claims data tell only of patterns and basic prescribing practices; however, when combined with medical review of claims data and patient charts, the data often forms the basis for punitive action against prescribers from claims denials, network exclusion, licensing board actions, and DEA involvement. It is important to understand the importance of writing your own script to guide investigators and your legal counsel through your medical decision-making process. Individual metrics will be defined and explained to raise awareness for providers of areas where increased vigilance will spare their practice from additional scrutiny or adverse action.

UAN: 0530-0000-22-011-L03-P
Rx hours: 0.30

Accreditation

PAINWeekEnd New Orleans 2022
This activity is provided by Global Education Group.

Target Audience

The educational design of this activity addresses the needs of frontline clinicians: physicians, nurses, nurse practitioners, physician assistants, and pharmacists involved in managing acute and chronic pain.

Statement of Need/Program Overview

Whether you're in a hospital or office-based practice, chronic pain patients are everywhere—and YOU are absorbing the burden of their care.

A just released report by the National Institutes of Health outlines positive steps that practitioners can take in response to the burgeoning problem of prescription medication abuse and to provide more effective pain management care to their patients. Key among these is access to pain education, and by participating in a PAINWeek Premiere Conference, you'll improve your skills in medication risk evaluation and mitigation, in pain assessment and diagnosis, and in the delivery of individualized multimodal treatment.

The PAINWeekEnd agenda is purposely constructed for the busy clinician, delivering a full day of relevant, practical information, together with the opportunity for interaction and exchange with faculty and fellow attendees.

Pain Management for the Main Street Practitioner has been created to streamline the clutter of information on assessment, evolving guidelines, risk management, and changing reimbursement scenarios. Join us for a day of clinical and practice management CE/CME designed expressly for frontline clinicians. Participants can receive 6.0 AMA PRA Category 1 Credits™ as they expand their capabilities in the assessment, diagnosis, and management of chronic pain conditions.

Learning Objectives

Describe the potential negative impact that bias, stigma, and social determinants of health can have in the assessment and treatment of pain
Summarize current stakeholder perspectives and oversight trends for opioid prescribing
Summarize how different types of opioid risk have varying levels of clinical impact
Identify key steps in meaningful risk evaluation of new patients and risk monitoring of established patients
Describe the importance of understanding the negotiation of pain and suffering
Describe how payers now measure and address patient risk
Cite potential drug interactions with cannabis
Summarize the general tension between the federal and state law regarding the status of cannabis

Faculty

Charles E. Argoff, MD
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Department of Neurology
Albany, NY

Timothy J. Atkinson, PharmD, BCPS, CPE
Clinical Pharmacy Practitioner, Pain Management
VA Tennessee Valley Healthcare System
Murfreesboro, TN

Jennifer Bolen, JD
Founder
The Legal Side of Pain
Lenoir City, TN

Brett B. Snodgrass, FNP-C, CPE, ACHPN, FAANP
Palliative Care Operations Director
Baptist Health Systems
Memphis, TN

Physician Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioner Continuing Education

Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 6.0 contact hour(s) (which includes 1.60 hour(s) of pharmacology).

Nursing Credit Designation

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 6.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.

Pharmacy Credit Designation

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for 6.0 contact hours (0.60 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge-based activity. UANs are in the agenda.

Instructions to Receive Credit

Please look for an email from outcomes@globaleducationgroup.com that will be sent to you following this Premiere Webinar. The email will have your personalized link to complete the online conference evaluation form needed to receive your CE/CME certificate. Upon completion of this form, you will be able to download, print, and save your certificate immediately! Please make sure to check your junk mail folder, as this email may be tagged as spam.

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (physical, dietary, etc). Please contact Patrick Kelly prior to the live event at (973) 415-5109.

For information about the accreditation of this program, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

Disclosure of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The planners and managers reported the following financial relationships or relationships to products or devices they have with ineligible company related to the content of this CME activity:

Rhys Williams, MSN, FNP-C, RN—Nothing to disclose
Kristin Delisi, NP—Nothing to disclose
Lindsay Borvansky—Nothing to disclose
Andrea Funk—Nothing to disclose
Liddy Knight—Nothing to disclose
Ashley Cann—Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

NEW ORLEANS, LA

This is a 1-day meeting and will provide 6 CE/CME credits.

Pain Management for the Main Street Practitioner

VENUE

FACULTY

MODERATOR